We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRG
1926
DELISTED
Franchise Group, Inc.
FRG
-35,285
Closed -$1.46M
ARNC
1927
DELISTED
Arconic Corporation
ARNC
-18,114
Closed -$464K
AMRS
1928
DELISTED
Amyris Inc.
AMRS
-443,848
Closed -$1.94M
MTEM
1929
DELISTED
Molecular Templates, Inc.
MTEM
-9,679
Closed -$501K
PDCE
1930
DELISTED
PDC Energy, Inc.
PDCE
-6,751
Closed -$491K
APPH
1931
DELISTED
AppHarvest, Inc. Common Stock
APPH
-21,749
Closed -$117K
USX
1932
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-140,920
Closed -$547K
EVLO
1933
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-3,644
Closed -$247K
MGI
1934
DELISTED
MoneyGram International, Inc. New
MGI
-23,264
Closed -$246K
TCRR
1935
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-158,593
Closed -$438K
MNTV
1936
DELISTED
Momentive Global Inc. Common Stock
MNTV
-104,563
Closed -$1.7M
OSH
1937
DELISTED
Oak Street Health, Inc.
OSH
-13,429
Closed -$361K
PEAR
1938
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
-28,900
Closed -$146K
CDAK
1939
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-101,279
Closed -$635K
ATCO
1940
DELISTED
Atlas Corp.
ATCO
-154,678
Closed -$2.27M
AIMC
1941
DELISTED
Altra Industrial Motion Corp
AIMC
-14,809
Closed -$577K
SJI
1942
DELISTED
South Jersey Industries, Inc.
SJI
-8,126
Closed -$281K
TCDA
1943
DELISTED
Tricida, Inc. Common Stock
TCDA
-22,983
Closed -$189K
EAR
1944
DELISTED
Eargo, Inc. Common Stock
EAR
-7,966
Closed -$843K
MNRL
1945
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
-10,974
Closed -$280K
PBFX
1946
DELISTED
PBF LOGISTICS LP
PBFX
-26,246
Closed -$368K
ZEN
1947
DELISTED
ZENDESK INC
ZEN
-5,583
Closed -$672K
TEN
1948
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-12,405
Closed -$227K
TWTR
1949
DELISTED
Twitter, Inc.
TWTR
-14,015
Closed -$542K
FMTX
1950
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
-16,845
Closed -$157K

Similar funds

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.